Related Experiment Video
Updated: Jun 23, 2025

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
Impact of Subspecialty Pediatric Palliative Care on Children with Heart Disease; A Systematic Review and
James Ting1, Kathryn Songer2, Valerie Bailey3
1Department of Pediatrics, Johns Hopkins University, Baltimore, MD, USA.
Insights
Specialty pediatric palliative care (SPPC) involvement for children with heart disease improves advance care planning and reduces end-of-life interventions. SPPC also significantly decreases parental stress, enhancing overall family well-being.
Area of Science:
- Pediatric Cardiology
- Palliative Care
- Systematic Review
Background:
- Limited research exists on the impact of specialty pediatric palliative care (SPPC) for pediatric heart disease patients.
- Existing literature emphasizes the importance of palliative care in pediatric cardiology.
Purpose of the Study:
- To systematically review the influence of SPPC on children with heart disease.
- To assess SPPC's effects on advance care planning, end-of-life care, and parental stress.
Main Methods:
- Systematic review of studies using keywords related to palliative care, quality of life, care satisfaction, and heart disease.
- Searched PubMed, EMBASE, CINAHL, CENTRAL, and Web of Science (December 2023).
- Followed PRISMA guidelines with independent reviewer screening and data extraction.
Main Results:
- Nine studies met inclusion criteria; designs were heterogeneous with a high risk of bias.
- SPPC was associated with increased documented advance care planning (RR 2.7) and resuscitation limits (RR 4.0).
- SPPC reduced active resuscitation at end-of-life (RR 0.5) and parental stress (RR 0.48).
Conclusions:
- A paucity of high-quality data exists regarding SPPC in pediatric heart disease.
- Findings suggest significant benefits of SPPC integration for patients and their families.
- Results align with SPPC benefits observed in other pediatric populations.
Abstract:
While many experts in pediatric cardiology have emphasized the importance of palliative care involvement, very few studies have assessed the influence of specialty pediatric palliative care (SPPC) involvement for children with heart disease. We conducted a systematic review using keywords related to palliative care, quality of life and care-satisfaction, and heart disease. We searched PubMed, EMBASE, CINAHL, CENTRAL and Web of Science in December 2023. Screening, data extraction and methodology followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations. Pairs of trained reviewers independently evaluated each article. All full texts excluded from the review were hand-screened for eligible references including systematic reviews in general pediatric populations. Two reviewers independently extracted: (1) study design; (2) methodology; (2) setting; (3) population; (4) intervention/exposure and control definition; (5) outcome measures; and (6) results. Of 4059 studies screened, 9 met inclusion criteria including two with overlapping patient data. Study designs were heterogenous, including only one randomized control and two historical control trials with SPPC as a prospective intervention. Overall, there was moderate to high risk of bias. Seven were single centers studies. In combined estimates, patients who received SPPC were more likely to have advance care planning documented (RR 2.7, [95%CI 1.6, 4.7], p < 0.001) and resuscitation limits (RR 4.0, [2.0, 8.1], p < 0.001), while half as likely to have active resuscitation at end-of-life ([0.3, 0.9], p = 0.032). For parental stress, receipt of SPPC improved scores by almost half a standard deviation (RR 0.48, 95%CI 0.10, 0.86) more than controls. Ultimately, we identified a paucity of high-quality data studying the influence of SPPC; however, findings correlate with literature in other pediatric populations. Findings suggest benefits of SPPC integration for patients with heart disease and their families.
Related Concept Videos
Continuing Care
Pathophysiology of Heart Failure
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

